Jonson & Johnson has paused its final stage clinical trials for a coronavirus candidate vaccine due to a patient's "unexplained illness." "We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant," the company said in a statement Monday. "Following our guidelines, the participant’s illness is being reviewed and evaluated by the ...